ADMA vs MSFT · P/E 22, rev $238.9M vs P/E 39, rev $331.84B
ADMA Biologics Inc (ADMA) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the ADMA and MSFT stock pages for the full models.
Not investment advice.